CAPER as a therapeutic target for triple negative breast cancer

Breast cancers (BCas) that lack expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) are referred to as triple negative breast cancers (TNBCs) and have the poorest clinical outcome. Once these aggressive tumors progress to distant...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Campbell, Mallory C., Pontiggia, Laura, Russell, Ashley Y., Schwarting, Roland, Camacho, Jeanette, Jasmin, Jean-Francois, Mercier, Isabelle
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2018
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6084388/
https://ncbi.nlm.nih.gov/pubmed/30100993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25719
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller